Royce & Associates’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Sell |
790,640
-203,660
| -20% | -$2.75M | 0.11% | 273 |
|
|
2025
Q1 | $8.61M | Sell |
994,300
-75,260
| -7% | -$652K | 0.09% | 322 |
|
|
2024
Q4 | $5.2M | Buy |
+1,069,560
| New | +$5.2M | 0.05% | 469 |
|
|
2022
Q3 | – | Sell |
-44,000
| Closed | -$1.21M | – | 960 |
|
|
2022
Q2 | $1.21M | Hold |
44,000
| – | – | 0.01% | 729 |
|
|
2022
Q1 | $1.66M | Buy |
+44,000
| New | +$1.66M | 0.01% | 745 |
|
|
2021
Q4 | – | Sell |
-11,450
| Closed | -$980K | – | 1006 |
|
|
2021
Q3 | $980K | Sell |
11,450
-13,750
| -55% | -$1.18M | 0.01% | 821 |
|
|
2021
Q2 | $1.56M | Buy |
25,200
+800
| +3% | +$49.5K | 0.01% | 794 |
|
|
2021
Q1 | $1.19M | Buy |
24,400
+1,500
| +7% | +$73.2K | 0.01% | 832 |
|
|
2020
Q4 | $714K | Buy |
22,900
+2,900
| +15% | +$90.4K | 0.01% | 850 |
|
|
2020
Q3 | $417K | Buy |
20,000
+5,100
| +34% | +$106K | ﹤0.01% | 877 |
|
|
2020
Q2 | $194K | Buy |
+14,900
| New | +$194K | ﹤0.01% | 936 |
|